Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PREOPERATIVE SKIN PREPARATION

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SURGICAL HAND SCRUB

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HEALTHCARE PERSONNEL HAND HYGIENE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SKIN WOUND & GENERAL SKIN CLEANSER

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 GLOBAL CHLORHEXIDINE GLUCONATE SOLUTION MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. By Application

5.2.4. U.S.

5.2.4.1. Market size and forecast, by Application

5.2.5. Canada

5.2.5.1. Market size and forecast, by Application

5.2.6. Mexico

5.2.6.1. Market size and forecast, by Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. By Application

5.3.4. Germany

5.3.4.1. Market size and forecast, by Application

5.3.5. France

5.3.5.1. Market size and forecast, by Application

5.3.6. UK

5.3.6.1. Market size and forecast, by Application

5.3.7. Italy

5.3.7.1. Market size and forecast, by Application

5.3.8. Rest of Europe

5.3.8.1. Market size and forecast, by Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. By Application

5.4.4. China

5.4.4.1. Market size and forecast, by Application

5.4.5. Japan

5.4.5.1. Market size and forecast, by Application

5.4.6. India

5.4.6.1. Market size and forecast, by Application

5.4.7. Australia

5.4.7.1. Market size and forecast, by Application

5.4.8. Korea

5.4.8.1. Market size and forecast, by Application

5.4.9. Rest of Asia-Pacific

5.4.9.1. Market size and forecast, by Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. By Application

5.5.4. Brazil

5.5.4.1. Market size and forecast, by Application

5.5.5. Saudi Arabia

5.5.5.1. Market size and forecast, by Application

5.5.6. South Africa

5.5.6.1. Market size and forecast, by Application

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by Application

Chapter: 6 COMPANY PROFILES

6.1. H&R HEALTHCARE LTD.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. CADILA PHARMACEUTICALS LTD.

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. BASIC PHARMA LIFE SCIENCE PVT. LTD.

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. PSK PHARMA PVT. LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. PROTON PHARMA PRIVATE LIMITED

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. ABHILASHA PHARMA PVT. LTD.

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. NEELKANTH HEALTHCARE PVT. LTD.

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. AFTON PHARMA

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. GLIDE CHEM PRIVATE LIMITED

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. SCEPTRE MEDICAL INDIA PRIVATE LIMITED

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments